Company Data
ProKidney Corp.
Ticker
PROK
Current Price
$1.33 -8.59%
Market Cap
$402.1M
Price Target
Refer to Report
Volume
1.7M
52wk Range
$1.3 - $3.4799
Overview
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient’s own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient’s own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.